Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible. Drugs (Pharmaceuticals), Health Insurance and Managed Care, Prices (Fares, Fees and Rates), GLP-1 RAs (Drug), Weight, Novo Nordisk A/S Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible. NYT > Business
Weight Loss Drug Will Be Offered for $499 a Month for Some Patients
